Back
Scholar Rock Holding Vs. NeuroBo Pharmaceuticals Industry Stock Comparison
Buy
84
SRRK
Scholar Rock Holding
Last Price:
27.73
Seasonality Move:
14.84%
Sell
23
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.51
Seasonality Move:
-18.3%
Buy
84
Scholar Rock Holding (SRRK)
is a Buy
Is Scholar Rock Holding a Buy, Sell or Hold?
- The current Scholar Rock Holding [SRRK] share price is $28.42. The Score for SRRK is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- SRRK is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
23
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?
- The current NeuroBo Pharmaceuticals [NRBO] share price is $2.67. The Score for NRBO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- NRBO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRRK Stock Price Chart
What is Scholar Rock Holding's stock price today?
-
The Scholar Rock Holding share price today is $28.42
The current trend is moderately bullish and SRRK is experiencing slight buying pressure.
NRBO Stock Price Chart
What is NeuroBo Pharmaceuticals's stock price today?
-
The NeuroBo Pharmaceuticals share price today is $2.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing slight selling pressure.
SRRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.99 | Buy |
| Relative Strength Index (14 RSI): | 62.14 | Buy |
| Chaikin Money Flow: | 183332 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.71 - 33.35) | Buy |
| Bollinger Bands (100): | (4.49 - 20.69) | Buy |
NRBO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 41.68 | Sell |
| Chaikin Money Flow: | -18758 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.57 - 2.97) | Sell |
| Bollinger Bands (100): | (2.99 - 4.33) | Sell |
SRRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.38 | Sell |
| 20-day SMA: | 28.11 | Buy |
| 50-day SMA: | 16.4 | Buy |
| 200-day SMA: | 13.48 | Buy |
| 8-day EMA: | 29.08 | Sell |
| 20-day EMA: | 26.11 | Buy |
| 50-day EMA: | 19.62 | Buy |
| 200-day EMA: | 13.76 | Buy |
NRBO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.75 | Sell |
| 20-day SMA: | 2.73 | Sell |
| 50-day SMA: | 3.13 | Sell |
| 200-day SMA: | 3.95 | Sell |
| 8-day EMA: | 2.72 | Sell |
| 20-day EMA: | 2.81 | Sell |
| 50-day EMA: | 3.1 | Sell |
| 200-day EMA: | 5.05 | Sell |
Scholar Rock Holding Earnings Growth & SRRK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.41 per share, and a decrease next year of $0.04 per share.
NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Scholar Rock Holding Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NeuroBo Pharmaceuticals Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||